scholarly journals Electron microscopic characterization of chick embryonic skeletal muscle proteoglycans.

1985 ◽  
Vol 100 (5) ◽  
pp. 1767-1776 ◽  
Author(s):  
D G Pechak ◽  
D A Carrino ◽  
A I Caplan

In this article, proteoglycans from embryonic chick leg muscle are quantitatively and qualitatively compared with day 8 high density cell culture cartilage proteoglycans by electron microscopy of proteoglycan-cytochrome c monolayers. The visualized proteoglycan profiles were separated into four categories according to shape, size, and complexity. The two major categories were further characterized by lengths of core proteins, lengths of side projections, and distance between side projections. Two large proteoglycans are identifiable in spread leg muscle preparations. One group has a core protein (mean length of 205 nm) from which extend long thin side projections that we interpret to be groups of chondroitin sulfate glycosaminoglycans with a mean length of 79 nm. This large chondroitin sulfate proteoglycan is the only type found in muscle cultures as determined both biochemically in the past and now by electron microscopy and is referred to as muscle proteoglycan. The second large proteoglycan has a mean core protein length of 250 nm and side projections that are visibly shorter (mean length of 38 nm) and thicker than those of the muscle proteoglycan. This group is referred to as the mesenchymal proteoglycan since its biosynthetic origin is still uncertain. We compare these two profiles with the chick cartilage chondroitin sulfate proteoglycan that has a mean core protein length of 202 nm and side projections with a mean length of 50 nm. The data presented here substantiate the earlier biochemical characterization of these noncartilage proteoglycans and establish the unique structural features of the muscle proteoglycan as compared with the similar profiles of the cartilage and mesenchymal proteoglycans.


1991 ◽  
Vol 56 (2) ◽  
pp. 706-708 ◽  
Author(s):  
Noboru Iijima ◽  
Atsuhiko Oohira ◽  
Toshio Mori ◽  
Katsuaki Kitabatake ◽  
Shinichi Kohsaka


1996 ◽  
Vol 5 (4) ◽  
pp. 445-451 ◽  
Author(s):  
Menelas N. Pangalos ◽  
Junichi Shioi ◽  
Spiros Efthimiopoulos ◽  
Anfan Wu ◽  
Nikolaos K. Robakis


2004 ◽  
Vol 165 (6) ◽  
pp. 881-891 ◽  
Author(s):  
Jianbo Yang ◽  
Matthew A. Price ◽  
Cheryl L. Neudauer ◽  
Christopher Wilson ◽  
Soldano Ferrone ◽  
...  

Melanoma chondroitin sulfate proteoglycan (MCSP) is an early cell surface melanoma progression marker implicated in stimulating tumor cell proliferation, migration, and invasion. Focal adhesion kinase (FAK) plays a pivotal role in integrating growth factor and adhesion-related signaling pathways, facilitating cell spreading and migration. Extracellular signal–regulated kinase (ERK) 1 and 2, implicated in tumor growth and survival, has also been linked to clinical melanoma progression. We have cloned the MCSP core protein and expressed it in the MCSP-negative melanoma cell line WM1552C. Expression of MCSP enhances integrin-mediated cell spreading, FAK phosphorylation, and activation of ERK1/2. MCSP transfectants exhibit extensive MCSP-rich microspikes on adherent cells, where it also colocalizes with α4 integrin. Enhanced activation of FAK and ERK1/2 by MCSP appears to involve independent mechanisms because inhibition of FAK activation had no effect on ERK1/2 phosphorylation. These results indicate that MCSP may facilitate primary melanoma progression by enhancing the activation of key signaling pathways important for tumor invasion and growth.



1999 ◽  
Vol 11 (3) ◽  
pp. 393-405 ◽  
Author(s):  
Hiroto Kawashima ◽  
Yong-Fei Li ◽  
Norifumi Watanabe ◽  
Jun Hirose ◽  
Mayumi Hirose ◽  
...  


1987 ◽  
Vol 7 (1) ◽  
pp. 33-40
Author(s):  
M A Bourdon ◽  
M Shiga ◽  
E Ruoslahti

We have examined genomic sequences and mRNA species hybridizing to a cDNA clone of a yolk sac carcinoma chondroitin sulfate proteoglycan designated PG19. Genomic blot hybridizations with cDNAs covering the majority of the PG19 mRNA sequence revealed 15 to 17 gene fragments. Similar analysis with probes representing either the propeptide or the combined core protein COOH-terminal domain and 3' untranslated sequences revealed single genomic fragments indicating that a single gene codes for the PG19 proteoglycan. Genomic blot analysis with cDNA sequences coding for the serine-glycine repeat of the core protein identified the same gene fragments observed with the entire PG19 cDNA, indicating that this coding region is homologous with sequences present in multiple genes. The same probes were also used to examine mRNA expression. In addition to the PG19 mRNA, several PG19-related mRNAs could be seen. These PG19-related mRNAs had homology with the serine-glycine coding sequence of the PG19 cDNA. These mRNAs may be coding for proteoglycans. The mRNA coding for PG19 appeared to be uniquely expressed in parietal yolk sac and mast cell lineages. The PG19 mRNA existed in different forms in parietal yolk sac and mast cell lines due to cell-type-specific differences in the length of the 5' untranslated sequences. These results indicate that expression of the PG19 proteoglycan gene is regulated both in terms of cell-type-specific transcription and selection of a transcriptional start site.



Sign in / Sign up

Export Citation Format

Share Document